1. Home
  2. BNGO vs DETX Comparison

BNGO vs DETX Comparison

Compare BNGO & DETX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bionano Genomics Inc.

BNGO

Bionano Genomics Inc.

N/A

Current Price

$1.11

Market Cap

12.5M

Sector

Industrials

ML Signal

N/A

Logo Liberty Defense Holdings Ltd. Common Shares

DETX

Liberty Defense Holdings Ltd. Common Shares

N/A

Current Price

$1.29

Market Cap

14.8M

ML Signal

N/A

Company Overview

Basic Information
Metric
BNGO
DETX
Founded
2003
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Telecommunications Equipment
Sector
Industrials
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
12.5M
14.8M
IPO Year
2018
2022

Fundamental Metrics

Financial Performance
Metric
BNGO
DETX
Price
$1.11
$1.29
Analyst Decision
Buy
Analyst Count
2
0
Target Price
★ $5.00
N/A
AVG Volume (30 Days)
★ 171.3K
26.9K
Earning Date
11-10-2026
11-27-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 94.50
N/A
EPS
N/A
★ N/A
Revenue
★ $12,000,735.00
N/A
Revenue This Year
$13.91
N/A
Revenue Next Year
$33.34
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 26.26
N/A
52 Week Low
$1.00
$1.23
52 Week High
$2.23
$4.25

Technical Indicators

Market Signals
Indicator
BNGO
DETX
Relative Strength Index (RSI) 35.93 29.17
Support Level $1.08 N/A
Resistance Level $1.19 $1.83
Average True Range (ATR) 0.06 0.21
MACD -0.00 -0.00
Stochastic Oscillator 19.97 17.88

Price Performance

Historical Comparison
BNGO
DETX

About BNGO Bionano Genomics Inc.

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.

About DETX Liberty Defense Holdings Ltd. Common Shares

Liberty Defense Holdings Ltd is engaged in the development and commercialization of security detection technologies such as airports, stadiums, schools, and more. The company's Hexwave product utilizes millimeter wave technology and Advanced 3D imaging to detect concealed threats. In addition to HEXWAVE, the company has licensed High-Definition Advanced Imaging Technology (HD-AIT) for body and shoe scanning. The Company operates through three distinct segments: Corporate, HEXWAVE, and Contract. The company generates the majority of its revenue from the Contract segment. Geographically, the company generates the majority of its revenue from the United States.

Share on Social Networks: